Pemetrexed for the first-line treatment of non-small-cell lung cancer

  • Technology appraisal guidance
  • TA181
  • Published: 
Download guidance (PDF)

Update information

February 2014: Implementation section updated to clarify that pemetrexed is recommended as an option for treating non-small-cell lung cancer.

ISBN: 978-1-4731-7081-0